Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by wyndeweston Jul 29, 2016 2:08pm
257 Views
Post# 25096522

RE:RE:RE:RE:RE:RE:RE:Zika Virus

RE:RE:RE:RE:RE:RE:RE:Zika VirusThanks for the post Viper.  Since Prometic is currently in the business of puifying blood and they seem to have a  state of the art system/process compared to others, I think a comment from Fred would be informative and not unreasonable or provocative. I'm not suggesting Prometic alter their course just because Zika is a cuurent concern.
Bullboard Posts